10.12.2014 08:22:47
|
Akers Biosciences Bags Order To Supply PIFA Heparin/PF4 Products To China
(RTTNews) - Akers Biosciences, Inc. (AKER, AKR.L) announced the receipt of an initial purchase order worth $1 million from NovoTek Therapeutics Inc. to supply PIFA Heparin PF4/Rapid Assay products in Mainland China.
NovoTek, a Beijing-based pharmaceutical and medical device business development company, owns the exclusive sales and marketing rights for the Company's PIFA Heparin/PF4 Rapid Assay products in China. The firm plans to deliver the order by this year end.
PIFA Heparin/PF4 Rapid Assay and PIFA PLUSS PF4 remain the only US FDA-cleared rapid manual assays that quickly determine if a patient being treated with the blood thinner heparin may be developing a drug allergy.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Akers Biosciences Incmehr Nachrichten
Keine Nachrichten verfügbar. |